Amendment "New nomenclature for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)" to the S2k guideline "Non-alcoholic fatty liver disease" (v.2.0/April 2022) of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)
- PMID: 39642895
- DOI: 10.1055/a-2408-3429
Amendment "New nomenclature for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)" to the S2k guideline "Non-alcoholic fatty liver disease" (v.2.0/April 2022) of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)
Conflict of interest statement
The overview of the declarations of interest of all experts are presented in the appendix.
LinkOut - more resources
Full Text Sources
Miscellaneous
